Literature DB >> 22149420

Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue.

Olaf Müller, Peter Meissner, Ulrich Mansmann.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22149420     DOI： 10.2165/11597790-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  5 in total

1.  Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.

Authors:  Germain Mandi; Steffen Witte; Peter Meissner; Boubacar Coulibaly; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Mamadou Sanon; Kirsten Wüst; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Journal:  Trop Med Int Health       Date:  2005-01       Impact factor: 2.622

Review 2.  Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Authors:  Ilan Youngster; Lidia Arcavi; Renata Schechmaster; Yulia Akayzen; Hen Popliski; Janna Shimonov; Svetlana Beig; Matitiahu Berkovitch
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.228

3.  Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.

Authors:  Peter E Meissner; Germain Mandi; Boubacar Coulibaly; Steffen Witte; Théophile Tapsoba; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; R Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Journal:  Malar J       Date:  2006-10-08       Impact factor: 2.979

4.  Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].

Authors:  Peter E Meissner; Germain Mandi; Steffen Witte; Boubacar Coulibaly; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Mamadou Sanon; Théophile Tapsoba; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Journal:  Malar J       Date:  2005-09-22       Impact factor: 2.979

5.  Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.

Authors:  Augustin Zoungrana; Boubacar Coulibaly; Ali Sié; Ingeborg Walter-Sack; Frank P Mockenhaupt; Bocar Kouyaté; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter Meissner; Olaf Müller
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240
  5 in total
  4 in total

1.  Revisiting the physiological effects of methylene blue as a treatment of cyanide intoxication.

Authors:  Philippe Haouzi; Maxime Gueguinou; Takashi Sonobe; Annick Judenherc-Haouzi; Nicole Tubbs; Mohamed Trebak; Joseph Cheung; Frederic Bouillaud
Journal:  Clin Toxicol (Phila)       Date:  2018-02-16       Impact factor: 4.467

2.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

3.  Antidotal effects of methylene blue against cyanide neurological toxicity: in vivo and in vitro studies.

Authors:  Philippe Haouzi; Marissa McCann; JuFang Wang; Xue-Qian Zhang; Jianliang Song; Ilker Sariyer; Diane Langford; Maryline Santerre; Nicole Tubbs; Annick Haouzi-Judenherc; Joseph Y Cheung
Journal:  Ann N Y Acad Sci       Date:  2020-05-06       Impact factor: 5.691

Review 4.  Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.

Authors:  G Lu; M Nagbanshi; N Goldau; M Mendes Jorge; P Meissner; A Jahn; F P Mockenhaupt; O Müller
Journal:  BMC Med       Date:  2018-04-25       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.